{
    "2018-12-20": [
        [
            {
                "time": "2018-12-03",
                "original_text": "Gilead Partners with Scholar Rock for Fibrotic Disease Drugs",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Scholar Rock",
                        "Fibrotic Disease Drugs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-04",
                "original_text": "AbbVie Rises 3%",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rises",
                        "3%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-05",
                "original_text": "Notable ETF Inflow Detected - XLV, ABBV, ABT, CVS",
                "features": {
                    "keywords": [
                        "ETF Inflow",
                        "XLV",
                        "ABBV",
                        "ABT",
                        "CVS"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-06",
                "original_text": "AbbVie Submits New Drug Application to U.S. FDA and Marketing Authorization Application to EMA for Upadacitinib for Treatment of Adults with Moderate to Severe Rheumatoid Arthritis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "FDA",
                        "EMA",
                        "Upadacitinib",
                        "Rheumatoid Arthritis"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-07",
                "original_text": "AbbVie to Present at the 37th Annual J.P. Morgan Healthcare Conference",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "J.P. Morgan",
                        "Healthcare Conference"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-08",
                "original_text": "3 Top Healthcare Stocks to Buy in December",
                "features": {
                    "keywords": [
                        "Healthcare Stocks",
                        "Buy",
                        "December"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}